Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated with Better Long-term Outcomes Compared with Standard of Care in Patients with Inflammatory Bowel Disease
- Konstantinos Papamichael
- , Anna Juncadella
- , Danny Wong
- , Shana Rakowsky
- , Lindsey A. Sattler
- , James P. Campbell
- , Byron P. Vaughn
- , Adam S. Cheifetz
Research output: Contribution to journal › Article › peer-review
134
Link opens in a new tab
Scopus
citations